Universal Brain Earns FDA 510(k) for Brain Function Technology
SAN FRANCISCO, Calif., July 13, 2026 Universal Brain has achieved a significant regulatory milestone after receiving U.S. Food and...
4-1BB
Advertisement
Leads Biolabs Secures Six ESMO 2026 Research Presentations
NANJING, China, July 13, 2026 Leads Biolabs has strengthened its position in global cancer immunotherapy after announcing that six...
Avance Clinical Unveils Asia Growth Strategy at BIO Asia–Taiwan
TAIPEI, Taiwan | July 10, 2026 Avance Clinical, the Australian-headquartered global Contract Research Organization (CRO), has announced its participation...
Leads Biolabs Secures Priority Review for Opamtistomig
NANJING, China | July 10, 2026 Nanjing Leads Biolabs Co., Ltd. has announced that the Center for Drug Evaluation...
Leads Biolabs’ Opamtistomig Shows Strong NSCLC Response Ahead of WCLC 2026
NANJING, China, May 28, 2026 Nanjing-based Leads Biolabs announced that updated Phase II clinical data for its proprietary PD-L1/4-1BB...
Advertisements
Leads Biolabs Wins Phase III Approval for Opamtistomig in Advanced EP-NEC
NANJING, China, May 18, 2026 Leads Biolabs announced that its proprietary PD-L1/4-1BB bispecific antibody Opamtistomig (LBL-024) has received approval...
Advertisement
